ELTX
Elicio Therapeutics Inc.
NASDAQ: ELTX · HEALTHCARE · BIOTECHNOLOGY
$10.62
+2.91% today
Updated 2026-04-30
Market cap
$215.05M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.58
Dividend yield
—
52W range
$5 – $15
Volume
0.1M
Elicio Therapeutics Inc. (ELTX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.30M | $6.58M | $4.03M | $1.49M | $2.88M | $28.31M | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | -9.8% | -38.8% | -63.1% | +93.7% | +883.1% | -100.0% | — | — | — |
| Cost of revenue | $3.67M | $3.17M | $380000.00 | $1.14M | $1.82M | $1.23M | $1.06M | $1.17M | $1.18M | $1.13M |
| Gross profit | $3.62M | $3.41M | $3.65M | $351000.00 | $1.06M | $27.08M | $-1.06M | $-1.17M | $-1.18M | $-1.13M |
| Gross margin | 49.7% | 51.8% | 90.6% | 23.6% | 36.9% | 95.6% | — | — | — | — |
| R&D | — | $196008.00 | $9.15M | $29.79M | $38.88M | $48.61M | $17.05M | $22.68M | $33.66M | $24.90M |
| SG&A | — | — | — | $2.80M | $3.00M | $7.54M | $5.63M | $11.90M | $11.33M | $12.81M |
| Operating income | $-419220.00 | $-397800.00 | $-14.34M | $-38.59M | $-55.27M | $-39.31M | $-23.73M | $-35.74M | $-44.99M | $-37.71M |
| Operating margin | -5.7% | -6.0% | -356.0% | -2595.2% | -1919.2% | -138.8% | — | — | — | — |
| EBITDA | $1.96M | $62540.00 | $-14.34M | $-40.16M | $-70.63M | $-51.92M | $-23.55M | $-32.97M | $-50.27M | $-36.59M |
| EBITDA margin | 26.9% | 1.0% | -355.9% | -2700.9% | -2452.5% | -183.4% | — | — | — | — |
| EBIT | $1.50M | $-397804.00 | $-14.34M | $-40.66M | $-71.26M | $-52.73M | $-24.61M | $-34.14M | $-51.44M | $-37.71M |
| Interest expense | $307450.00 | $300432.00 | — | — | $8.85M | $876442.00 | $3.60M | $1.06M | $455000.00 | $1.13M |
| Income tax | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $307303.00 | $632241.00 | $-20.02M | $-40.66M | $-80.11M | $-26.40M | $-28.21M | $-35.20M | $-51.90M | $-39.57M |
| Net income growth (YoY) | — | +105.7% | -3267.3% | -103.0% | -97.0% | +67.0% | -6.8% | -24.8% | -47.5% | +23.8% |
| Profit margin | 4.2% | 9.6% | -497.0% | -2734.2% | -2781.5% | -93.2% | — | — | — | — |